TerminatedNCT04634669
Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)
Medication studyAges 18+United StatesDepression
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- Little Rock and 19 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 23, 2020
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 181
- Sponsor
- Axsome Therapeutics, Inc.
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT04634669
- Official title
Show the full official title
An Open-Label Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Treatment Resistant Depression
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Little Rock · Redlands · Sherman Oaks
17 more locations
- Upland
- Miami
- Miami Lakes
- Orlando
- Chicago
- Boston
- Berlin
- Rochester
- Staten Island
- Hickory
- Raleigh
- Cincinnati
- Middleburg Heights
- Media
- Dallas
- Friendswood
- Everett
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Axsome Therapeutics, Inc.
Does this study involve medication?
Yes. The study involves medication, including AXS-05 (dextromethorphan-bupropion).
Who can participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
